mesothelioma exposure particles

July 30, 2010 | By admin In Mesothelioma |

Press Release
Rosetta Genomics Ltd. Posted on:29 Jul 10 Rosetta Genomics, Ltd. (NASDQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Genekor S.A, a leading molecular diagnostic service provider in Greece, announced today the signing of an exclusive distribution agreement for three of Rosetta Genomics’ diagnostic tests in Greece.

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Other Related Posts:

  • mesothelioma asbestos diseases
  • mesothelioma provides
  • mesothelioma risk factors

    • No Comments

    Leave a reply

    Security Code: